Aerobic glycolysis in osteoblasts
- PMID: 25200872
- PMCID: PMC4216598
- DOI: 10.1007/s11914-014-0235-y
Aerobic glycolysis in osteoblasts
Abstract
Osteoblasts, the chief bone-making cells in the body, are a focus of osteoporosis research. Although teriparatide, a synthetic fragment of the human parathyroid hormone (PTH), has been an effective bone anabolic drug, there remains a clinical need for additional therapeutics that safely stimulates osteoblast number and function. Work in the past several decades has provided unprecedented clarity about the roles of growth factors and transcription factors in regulating osteoblast differentiation and activity, but whether these factors may regulate cellular metabolism to influence cell fate and function has been largely unexplored. The past few years have witnessed a resurgence of interest in the cellular metabolism of osteoblasts, with the hope that elucidation of their metabolic profile may open new avenues for developing bone anabolic agents. Here we review the current understanding about glucose metabolism in osteoblasts.
Conflict of interest statement
E Esen and F Long both declare no conflicts of interest.
Figures
References
-
- Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nature reviews. Molecular cell biology. 2012 Jan;13(1):27–38. - PubMed
-
- Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Genet. 2003 Aug;4(8):638–649. - PubMed
-
- Clemens TL, Karsenty G. The osteoblast: an insulin target cell controlling glucose homeostasis. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2011 Apr;26(4):677–680. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
